T-1210
- Generic Name
- T-1210
Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
Phase 2
Completed
- Conditions
- Seasonal Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2011-04-28
- Last Posted Date
- 2012-04-12
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 60
- Registration Number
- NCT01344083
- Locations
- 🇫🇷
Pierre Huguet, Clermont ferrand, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath